← Back to Krebs Biochemicals & Industries Limited Overview

📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

KREBSBIOPharmaceuticals

Krebs Biochemicals & Industries Limited — Financial Ratios & Key Metrics

₹39.75

-6.96%

P/E RatioN/AxIndustry: 31.77x

ROEN/AReturn on equity

ROCE-30.09%Return on capital

Debt/EquityN/ADebt free ✓

💎

Valuation & Profitability

P/E Ratio

N/Ax

Industry Average P/E

31.77x

Dividend Yield

0.00%

Market Cap

₹141.35 (Cr)

Sales Growth 5Y

5.33%

Profit Growth 5Y

1.23%

EPS Growth 5Y

4.02%

OPM 5Y Avg

-35.14%

📉

Price Returns

1 Month

-5.69%

3 Months

-11.49%

6 Months

-15.85%

1 Year

-37.48%

52W Low

₹43

Current

₹40

52W High

₹114

-5% of 52-week range — Near lows

🔬

Technical Indicators

Oversold

Selling pressure is heavy — potential reversal zone.

SMA 50

₹56

▼ Price below SMA 50 — Bearish

SMA 200

₹70

▼ Long-term downtrend

Volume Signal

112% of avg

Average volume

Technical indicators are for educational purposes only. Not investment advice.

More on Krebs Biochemicals & Industries Limited

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.